Laryngeal Cancer

Our specialists are experts in diagnosing and treating laryngeal cancer. We build a care plan that is tailored for your needs and delivered with compassion. Our head and neck surgeons specialize in minimally invasive surgery to remove laryngeal cancer and are leaders in reconstructive surgical techniques. Throughout your treatment and recovery, we offer support services such as therapy to help maintain or restore your speech and ability to swallow.

Clinical Trials and Research Studies

Phase N/A

The AIM-HN and SEQ-HN Study: A 2 Cohort Non-comparative Pivotal Study Evaluating the Efficacy of Tipifarnib in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC) with HRAS Mutations (AIM-HN) and the Impact of HRAS Mutations on Response to First Line Systemic Therapies for HNSCC (SEQ-HN)

Learn More

Phase 3

MK-3475 (SCH 9000475) as neoadjuvant and adjuvant therapy in Stage III-IVA resectable

Learn More

Phase 1

A Phase 1 Open-Label Multicenter Study to Assess the Safety Tolerability and Immunogenicity of mRNA-4157 Alone in Subjects with Resected Solid Tumors and in Combination with Pembrolizumab in Subjects with Unresectable Solid Tumors

Learn More

Phase 1

A Phase 1 Open-Label Dose-Escalation and Cohort Expansion First-in-Human Study of the Safety Tolerability Activity and Pharmacokinetics of REGN3767 (anti-LAG-3 mAb) Administered Alone or in Combination with REGN2810 (anti-PD-1 mAb) in Patients with Ad

Learn More